Clinical Trials Browser

Phase 2 × Unknown × ER Positive, HER2 Negative Breast Cancer × Clear all

NCT01709370 2013-12-31

Letrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal Women

Phase 2 Unknown

ER Positive, HER2 Negative Breast Cancer